Mental health disorders may emerge from an overactive immune system targeting the brain's own neural connections. This research reveals how genetic variations in complement protein C4A—part of the immune system's cleanup crew—directly influence schizophrenia risk by ramping up synaptic pruning, the process that eliminates neural connections during brain development. The study demonstrates that individuals carrying more copies of the C4A gene face higher schizophrenia risk, with each additional copy correlating with increased protein production and more aggressive pruning of brain synapses. This finding bridges genetics with neurobiology, showing how inherited immune system variants can derail normal brain maturation. The research analyzed C4A gene copy numbers across diverse populations, measuring both peripheral blood protein levels and examining how different immune cell populations contribute to complement production. Results confirmed that higher C4A expression translates to elevated synaptic elimination, potentially explaining why some individuals develop psychotic symptoms while others with similar environmental exposures do not. This immune-mediated mechanism represents a paradigm shift from purely neurotransmitter-based models of psychiatric illness toward understanding schizophrenia as a neurodevelopmental disorder driven by inflammatory processes. The findings have immediate implications for early intervention strategies, suggesting that monitoring complement protein levels could identify at-risk individuals before symptom onset. More broadly, this work validates emerging therapeutic approaches targeting neuroinflammation rather than traditional dopamine pathways, potentially opening new treatment avenues for the 24 million people worldwide living with schizophrenia and related psychotic disorders.